FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2130212171> ?p ?o ?g. }

• W2130212171 endingPage "267" @default.
• W2130212171 startingPage "259" @default.
• W2130212171 abstract "Osteoarthritis is a chronic disease characterized by irreversible damage to joint structures, including loss of articular cartilage, osteophyte formation, alterations in the subchondral bone and synovial inflammation. It has been shown that chondroitin sulfate interferes with the progression of structural changes in joint tissues and is used in the management of patients with osteoarthritis.This review summarizes data from relevant reports describing the mechanisms of action of chondroitin sulfate that may explain the beneficial effects of the drug and examines the evidence for clinical efficacy of oral chondroitin sulfate in osteoarthritis. Data included in the review were derived from a literature search in PubMed. Literature searches were performed in PubMed using the search terms 'chondroitin sulfate', 'pharmaceutical-grade', 'osteoarthritis', 'randomized clinical trials', 'humans'. The MEDLINE database was searched from January 1996 through August 2012 for all randomized controlled trials, meta-analyses, systematic reviews, and review articles of chondroitin sulfate in osteoarthritis.Chondroitin sulfate exerts in vitro a beneficial effect on the metabolism of different cell lines: chondrocytes, synoviocytes and cells from subchondral bone, all involved in osteoarthritis. It increases type II collagen and proteoglycan synthesis in human articular chondrocytes and is able to reduce the production of some pro-inflammatory factors and proteases, to reduce the cellular death process, and improve the anabolic/catabolic balance of the extracellular cartilage matrix (ECM). Clinical trials have reported a beneficial effect of chondroitin sulfate on pain and function. The structure-modifying effects of chondroitin sulfate have been reported and analyzed in recent meta-analyses. The results in knee osteoarthritis demonstrate a small but significant reduction in the rate of decline in joint space width. Because chondroitin sulfate quality of several nutraceuticals has been found to be poor, it is recommended that pharmaceutical-grade chondroitin sulfate is used rather than food supplements in the treatment of OA. Chondroitin sulfate is recommended by several guidelines from international societies in the management of knee and hip OA. Furthermore, its safety profile is favorable when compared with many other therapies used in OA.Chondroitin sulfate is an effective and safe treatment option for patients with osteoarthritis." @default.
• W2130212171 created "2016-06-24" @default.
• W2130212171 creator A5012205838 @default.
• W2130212171 creator A5012454701 @default.
• W2130212171 creator A5026165132 @default.
• W2130212171 creator A5080921373 @default.
• W2130212171 creator A5087935214 @default.
• W2130212171 date "2013-01-31" @default.
• W2130212171 modified "2023-09-30" @default.
• W2130212171 title "Symptom and structure modification in osteoarthritis with pharmaceutical-grade chondroitin sulfate: what’s the evidence?" @default.
• W2130212171 cites W1487036716 @default.
• W2130212171 cites W1595864962 @default.
• W2130212171 cites W1966066361 @default.
• W2130212171 cites W1966095355 @default.
• W2130212171 cites W1969190120 @default.
• W2130212171 cites W1969803821 @default.
• W2130212171 cites W1978077869 @default.
• W2130212171 cites W1979653063 @default.
• W2130212171 cites W1982616176 @default.
• W2130212171 cites W1988924807 @default.
• W2130212171 cites W1991950326 @default.
• W2130212171 cites W2008797359 @default.
• W2130212171 cites W2010802338 @default.
• W2130212171 cites W2011487877 @default.
• W2130212171 cites W2017956676 @default.
• W2130212171 cites W2019989482 @default.
• W2130212171 cites W2021570058 @default.
• W2130212171 cites W2023067703 @default.
• W2130212171 cites W2025143496 @default.
• W2130212171 cites W2025797414 @default.
• W2130212171 cites W2027597946 @default.
• W2130212171 cites W2030682870 @default.
• W2130212171 cites W2034803375 @default.
• W2130212171 cites W2035833931 @default.
• W2130212171 cites W2036491373 @default.
• W2130212171 cites W2042919418 @default.
• W2130212171 cites W2045450260 @default.
• W2130212171 cites W2048889862 @default.
• W2130212171 cites W2052651983 @default.
• W2130212171 cites W2056742992 @default.
• W2130212171 cites W2058147305 @default.
• W2130212171 cites W2058858875 @default.
• W2130212171 cites W2059605557 @default.
• W2130212171 cites W2062759625 @default.
• W2130212171 cites W2065485575 @default.
• W2130212171 cites W2065556610 @default.
• W2130212171 cites W2067610361 @default.
• W2130212171 cites W2072293269 @default.
• W2130212171 cites W2075835363 @default.
• W2130212171 cites W2076221329 @default.
• W2130212171 cites W2076816724 @default.
• W2130212171 cites W2083092719 @default.
• W2130212171 cites W2086438508 @default.
• W2130212171 cites W2090075402 @default.
• W2130212171 cites W2105501783 @default.
• W2130212171 cites W2105539667 @default.
• W2130212171 cites W2106085759 @default.
• W2130212171 cites W2112870271 @default.
• W2130212171 cites W2113079259 @default.
• W2130212171 cites W2113737049 @default.
• W2130212171 cites W2115805053 @default.
• W2130212171 cites W2121319738 @default.
• W2130212171 cites W2122435770 @default.
• W2130212171 cites W2124787336 @default.
• W2130212171 cites W2124790232 @default.
• W2130212171 cites W2131049610 @default.
• W2130212171 cites W2132420892 @default.
• W2130212171 cites W2135119721 @default.
• W2130212171 cites W2135532785 @default.
• W2130212171 cites W2137637067 @default.
• W2130212171 cites W2140215285 @default.
• W2130212171 cites W2146385165 @default.
• W2130212171 cites W2158841776 @default.
• W2130212171 cites W2160239047 @default.
• W2130212171 cites W2161739351 @default.
• W2130212171 cites W2165961622 @default.
• W2130212171 cites W2167792025 @default.
• W2130212171 cites W2171335020 @default.
• W2130212171 cites W2761316764 @default.
• W2130212171 cites W4229810505 @default.
• W2130212171 cites W4248226706 @default.
• W2130212171 cites W4254899257 @default.
• W2130212171 doi "https://doi.org/10.1185/03007995.2012.753430" @default.
• W2130212171 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23186102" @default.
• W2130212171 hasPublicationYear "2013" @default.
• W2130212171 type Work @default.
• W2130212171 sameAs 2130212171 @default.
• W2130212171 citedByCount "54" @default.
• W2130212171 countsByYear W21302121712013 @default.
• W2130212171 countsByYear W21302121712014 @default.
• W2130212171 countsByYear W21302121712015 @default.
• W2130212171 countsByYear W21302121712016 @default.
• W2130212171 countsByYear W21302121712017 @default.
• W2130212171 countsByYear W21302121712018 @default.
• W2130212171 countsByYear W21302121712019 @default.
• W2130212171 countsByYear W21302121712020 @default.
• W2130212171 countsByYear W21302121712021 @default.
• W2130212171 countsByYear W21302121712022 @default.

• next